Search Results

You are looking at 1 - 5 of 5 items for :

  • "chronic hepatitis C" x
  • Biology and Life Sciences x
  • Refine by Access: All Content x
Clear All

Arif, A., Levine, R. A., Sanderson, S. O., Bank, L., Velu, R. P., Shah, A., Mahl, T. C., Gregory, D. H. (2003) Regression of fibrosis in chronic hepatitis C after therapy with interferon and ribavirin. Dig

Restricted access

Lee, I. N., Chen, C. H., Sheu, J. C., Lee, H. S., Huang, G. T., Chen, D. S., Yu, C. Y., Wen, C. L., Lu, F. J., Chow, L. P. (2006) Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCV-related hepatocellular

Restricted access

, A., Almer, S. (2012) High prevalence of autoantibodies to C-reactive protein in patients with chronic hepatitis C infection: association with liver fibrosis and portal inflammation. Hum. Immunol. 73, 382

Restricted access

van Rossum TG, Vulto AG, Hop WC, Brouwer JT, Niesters HG, Schalm SW: Intravenous glycyrrhizin for the treatment of chronic hepatitis C: a double-blind, randomized, placebo-controlled phase I/II trial. J Gastroenterol Hepatol 14(11), 1093–1099 (1999

Open access
European Journal of Microbiology and Immunology
Authors: H. Frickmann, S. Jungblut, T. O. Hirche, U. Groß, M. Kuhns, and Andreas Erich Zautner

function in COPD patients with chronic hepatitis C virus infection: a preliminary study based on small numbers of patients Chest 123 2 596 – 599

Restricted access